All In MedTech

FDA Clearance Tracker · P060040-S011

HEARTMATE II LEFT VENTRICULAR ASSIST SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 13, 2010 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 13, 2010

Approved

Time to decision

27 days

Received Aug 17, 2010. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P060040-S011
Device name
HEARTMATE II LEFT VENTRICULAR ASSIST SYSTEM
Applicant location
Pleasanton, CA
Received
Aug 17, 2010
Decided
Sep 13, 2010
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P060040

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code DSQ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR UPDATED INSTRUCTIONS FOR USE (IFU) INCLUDING POST-APPROVAL STUDY RESULTS.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.